Bu W, Li Y
Adv Exp Med Biol. 2025; 1464():123-148.
PMID: 39821024
DOI: 10.1007/978-3-031-70875-6_8.
Nicotra R, Lutz C, Messal H, Jonkers J
J Mammary Gland Biol Neoplasia. 2024; 29(1):12.
PMID: 38913216
PMC: 11196369.
DOI: 10.1007/s10911-024-09566-0.
Bu W, Li Y
Cold Spring Harb Perspect Med. 2023; 14(3.
PMID: 37217281
PMC: 10810718.
DOI: 10.1101/cshperspect.a041328.
Zhang Y, Xia Y, Zhang J, Deb S, Garrett S, Sun J
Gut Microbes. 2023; 15(1):2202593.
PMID: 37074210
PMC: 10120454.
DOI: 10.1080/19490976.2023.2202593.
Skrajnowska D, Idkowiak J, Szterk A, Ofiara K, Augustyniak K, Bobrowska-Korczak B
Foods. 2023; 12(6).
PMID: 36981273
PMC: 10047967.
DOI: 10.3390/foods12061348.
Short-term PI3K Inhibition Prevents Breast Cancer in Preclinical Models.
Ku A, Young A, Ibrahim A, Bu W, Jiang W, Lin M
Cancer Prev Res (Phila). 2022; 16(2):65-73.
PMID: 36343340
PMC: 9905287.
DOI: 10.1158/1940-6207.CAPR-22-0275.
Ethanol Ablation Therapy Drives Immune-Mediated Antitumor Effects in Murine Breast Cancer Models.
Nief C, Swartz A, Chelales E, Sheu L, Crouch B, Ramanujam N
Cancers (Basel). 2022; 14(19).
PMID: 36230591
PMC: 9564135.
DOI: 10.3390/cancers14194669.
The potential of lunasin extract for the prevention of breast cancer progression by upregulating E-Cadherin and inhibiting ICAM-1.
Kusmardi K, Wiyarta E, Rusdi N, Maulana A, Estuningtyas A, Sunaryo H
F1000Res. 2021; 10:902.
PMID: 34691393
PMC: 8506221.
DOI: 10.12688/f1000research.55385.1.
Experimental models of endocrine responsive breast cancer: strengths, limitations, and use.
Clarke R, Jones B, Sevigny C, Hilakivi-Clarke L, Sengupta S
Cancer Drug Resist. 2021; 4:762-783.
PMID: 34532657
PMC: 8442978.
DOI: 10.20517/cdr.2021.33.
Different properties of mammary carcinogenesis induced by two chemical carcinogens, DMBA and PhIP, in heterozygous BALB/c knockout mice.
Machida Y, Imai T
Oncol Lett. 2021; 22(4):738.
PMID: 34466150
PMC: 8387855.
DOI: 10.3892/ol.2021.12999.
50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?.
Jordan V
Endocr Relat Cancer. 2020; 28(1):R11-R30.
PMID: 33151906
PMC: 7780369.
DOI: 10.1530/ERC-20-0335.
A Multistage Murine Breast Cancer Model Reveals Long-Lived Premalignant Clones Refractory to Parity-Induced Protection.
Li S, Gestl S, Gunther E
Cancer Prev Res (Phila). 2019; 13(2):173-184.
PMID: 31699706
PMC: 7007345.
DOI: 10.1158/1940-6207.CAPR-19-0322.
Mapping Mammary Tumor Traits in the Rat.
Flister M, Joshi A, Bergom C, Rui H
Methods Mol Biol. 2019; 2018:249-267.
PMID: 31228161
PMC: 9272588.
DOI: 10.1007/978-1-4939-9581-3_12.
Chemically induced carcinogenesis in rodent models of aging: assessing organismal resilience to genotoxic stressors in geroscience research.
Csiszar A, Balasubramanian P, Tarantini S, Yabluchanskiy A, Zhang X, Springo Z
Geroscience. 2019; 41(2):209-227.
PMID: 31037472
PMC: 6544731.
DOI: 10.1007/s11357-019-00064-4.
Successful Targeted Therapies for Breast Cancer: the Worcester Foundation and Future Opportunities in Women's Health.
Abderrahman B, Jordan V
Endocrinology. 2018; 159(8):2980-2990.
PMID: 29931061
PMC: 6963694.
DOI: 10.1210/en.2018-00263.
While it is not deliberate, much of today's biomedical research contains logical and technical flaws, showing a need for corrective action.
He Y, Yuan C, Chen L, Liu Y, Zhou H, Xu N
Int J Med Sci. 2018; 15(4):309-322.
PMID: 29511367
PMC: 5835702.
DOI: 10.7150/ijms.23215.
Dimethyl-Benz(a)anthracene: A mammary carcinogen and a neuroendocrine disruptor.
Kerdelhue B, Forest C, Coumoul X
Biochim Open. 2018; 3:49-55.
PMID: 29450131
PMC: 5801823.
DOI: 10.1016/j.biopen.2016.09.003.
A high-fat diet increases the incidence of mammary cancer inc-Ha- proto-oncogene transgenic rats.
Magaki M, Ishii H, Yamasaki A, Kitai Y, Kametani S, Nakai R
J Toxicol Pathol. 2017; 30(2):145-152.
PMID: 28458452
PMC: 5406593.
DOI: 10.1293/tox.2016-0052.
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery.
Suba Z
Recent Pat Anticancer Drug Discov. 2016; 11(3):254-66.
PMID: 27087654
PMC: 5074059.
DOI: 10.2174/1574892811666160415160211.
Effect of liposomal celecoxib on proliferation of colon cancer cell and inhibition of DMBA-induced tumor in rat model.
Perumal V, Banerjee S, Das S, Sen R, Mandal M
Cancer Nanotechnol. 2015; 2(1-6):67-79.
PMID: 26069486
PMC: 4451972.
DOI: 10.1007/s12645-011-0017-5.
